Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo

被引:63
作者
Westerhof, W
Nieuweboer-Krobotova, L
Mulder, PGH
Glazenburg, EJ
机构
[1] Netherlands Inst Pigmentary Disorders, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands
[3] Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[4] Glaxo Wellcome BV, Dept Med, Zeist, Netherlands
关键词
D O I
10.1001/archderm.135.9.1061
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To compare the efficacy and safety of using a combination of fluticasone propionate (FP) and UV-A with that of either drug used alone in the long-term treatment of vitiligo. Design: Prospective, randomized, controlled, left-right comparison study;. Repigmentation was judged by a single dermatologist (L.N.-K.) and skin thickness was scored by a pathologist (using biopsy samples), a dermatologist (L.N.-K.) (visually), and patients (using a standard questionnaire). Setting: Netherlands Institute for Pigmentary Disorders, Amsterdam. Patients: Patients with lesions on arms, legs, and trunk were treated on 2 symmetrical lesions for 9 months with FP alone and a combination of FP and UV-A (FP group) or with UV-A alone and a combination of FP and UV-A (UV-A group). Fluticasone propionate cream was applied once daily at about bedtime, and UV-A (10 J/cm(2)) exposure was twice a week. Patients attended the clinic at 3-month intervals. Results: One hundred thirty-five patients were included. 96 of whom were evaluable after 9 months. Patients not reaching the end point withdrew because of insufficient repigmentation (n = 23), decreased motivation (n = 11), or protocol violations (n = 5). No patient (irrespective of whether they withdrew) experienced any adverse effects. The FP and UV-A groups were comparable with respect to sex, age, and location of lesions. On average, combination treatment was 3 times more effective than either UV-A or FP treatment alone. In the FP group, no atrophy was seen after 9 months with either treatment. In the UV-A group, a little atrophy was detected twice: as well during UV-A treatment alone as during combination treatment. Conclusions: Combination treatment with FP and W-A is much more effective in reaching complete repigmentation than are FP and UV-A used alone, but large interindividual differences occur. Fluticasone propionate, UV-X, and a combination of FP and UV-A seem to be safe for long-term treatment. of vitiligo.
引用
收藏
页码:1061 / 1066
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 1976, PIGMENT CELL
[2]   TREATMENT OF VITILIGO WITH TOPICAL CORTICOSTEROIDS - LIGHT AND ELECTRON-MICROSCOPIC STUDIES [J].
BLEEHEN, SS .
BRITISH JOURNAL OF DERMATOLOGY, 1976, 94 :43-50
[3]  
BROSTOFF J, 1969, LANCET, V2, P177
[4]   OBSERVATIONS ON SYSTEMIC EFFECT OF TOPICAL CLOBETASOL PROPIONATE (DERMOVATE) [J].
CARRUTHERS, JA ;
AUGUST, PJ ;
STAUGHTON, RCD .
BMJ-BRITISH MEDICAL JOURNAL, 1975, 4 (5990) :203-204
[5]   DOUBLE-BLIND TRIAL OF 0.05 PERCENT CLOBETASOL PROPRIONATE IN TREATMENT OF VITILIGO [J].
CLAYTON, R .
BRITISH JOURNAL OF DERMATOLOGY, 1977, 96 (01) :71-73
[6]   ASSOCIATION OF HLA-DR4 WITH VITILIGO [J].
FOLEY, LM ;
LOWE, NJ ;
MISHELOFF, E ;
TIWARI, JL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 8 (01) :39-40
[7]   GLUCOCORTICOID STIMULATES MELANOGENESIS AND TYROSINASE GENE-EXPRESSION IN B16 MELANOMA-CELLS [J].
ITO, A ;
TANAKA, C ;
TAKEUCHI, T ;
MISHIMA, Y .
PIGMENT CELL RESEARCH, 1991, 4 (5-6) :247-251
[8]  
Juhlin L, 1996, CUTIS, V57, P51
[9]   TREATMENT OF VITILIGO WITH 0.1 PERCENT BETAMETHASONE 17-VALERATE IN ISOPROPYL-ALCOHOL - DOUBLE-BLIND TRIAL [J].
KANDIL, E .
BRITISH JOURNAL OF DERMATOLOGY, 1974, 91 (04) :457-&
[10]   VITILIGO - RESPONSE TO 0.3 PERCENT BETAMETHASONE 17 VALERATE IN FLEXIBLE COLLODION [J].
KANDIL, E .
DERMATOLOGICA, 1970, 141 (04) :277-&